Physician Wealth Advisors’s Rocket Pharmaceuticals RCKT Stock Holding History

Physician Wealth Advisors’s Portfolio RCKT Stock Details RCKT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.94K	Hold	568	–	–	﹤0.01%	1516
2026 Q1	$2.03K	Hold	568	–	–	﹤0.01%	1346
2025 Q4	$1.99K	Sell	568 -594	-51%	-$2.03K	﹤0.01%	1290
2025 Q3	$3.79K	Buy	1,162 +672	+137%	+$2.12K	﹤0.01%	999
2025 Q2	$1.2K	Buy	490 +375	+326%	+$1.9K	﹤0.01%	1274
2025 Q1	$768	Buy	115 +36	+46%	+$356	﹤0.01%	1248
2024 Q4	$994	Buy	+79	New	+$1.19K	﹤0.01%	944

Other funds holding RCKT

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Physician Wealth Advisors's RCKT Position: Q2 2026 in Review

Physician Wealth Advisors held its Rocket Pharmaceuticals (RCKT) position steady in Q2 2026 at 568 shares worth $1.94K. The position accounts for ﹤0.01% of the portfolio, ranked #1516.

Physician Wealth Advisors first reported a position in RCKT in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.79K in Q3 2025. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

Physician Wealth Advisors held 568 shares of Rocket Pharmaceuticals worth $1.94K as of Q2 2026.
Physician Wealth Advisors left its Rocket Pharmaceuticals share count unchanged in Q2 2026.
Rocket Pharmaceuticals made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #1516 holding.
Physician Wealth Advisors first reported a position in Rocket Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
Physician Wealth Advisors's Rocket Pharmaceuticals position peaked at $3.79K in Q3 2025.
180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.